Stephen K L Chia (Stephen Chia, Stephen K Chia)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Topics

Positive Breast Cancer

Sentinel Lymph Node

Epidermal Growth Factor Receptor

Patient Reported

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Breast cancer research : BCR

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Priya Rastogi, Hanna Bandos, Peter C Lucas, Laura van 't Veer, Jia-Perng J Wei, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Andrea R Menicucci, M William Audeh, Norman Wolmark, Eleftherios P P Mamounas
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Eleftherios P P Mamounas, Hanna Bandos, Priya Rastogi, Yi Zhang, Kai Treuner, Peter C Lucas, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Dennis C Sgroi, Catherine A Schnabel, Norman Wolmark
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Eleftherios P P Mamounas, Hanna Bandos, Priya Rastogi, Yi Zhang, Kai Treuner, Peter C Lucas, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Dennis C Sgroi, Catherine A Schnabel, Norman Wolmark
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Priya Rastogi, Hanna Bandos, Peter C Lucas, Laura van 't Veer, Jia-Perng J Wei, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Andrea R Menicucci, M William Audeh, Norman Wolmark, Eleftherios P P Mamounas
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Priya Rastogi, Hanna Bandos, Peter C Lucas, Laura van 't Veer, Jia-Perng J Wei, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Andrea R Menicucci, M William Audeh, Norman Wolmark, Eleftherios P P Mamounas
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Eleftherios P P Mamounas, Hanna Bandos, Priya Rastogi, Yi Zhang, Kai Treuner, Peter C Lucas, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Dennis C Sgroi, Catherine A Schnabel, Norman Wolmark
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Eleftherios P P Mamounas, Hanna Bandos, Priya Rastogi, Yi Zhang, Kai Treuner, Peter C Lucas, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Dennis C Sgroi, Catherine A Schnabel, Norman Wolmark
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Eleftherios P P Mamounas, Hanna Bandos, Priya Rastogi, Yi Zhang, Kai Treuner, Peter C Lucas, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Dennis C Sgroi, Catherine A Schnabel, Norman Wolmark
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Priya Rastogi, Hanna Bandos, Peter C Lucas, Laura van 't Veer, Jia-Perng J Wei, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Andrea R Menicucci, M William Audeh, Norman Wolmark, Eleftherios P P Mamounas
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Eleftherios P P Mamounas, Hanna Bandos, Priya Rastogi, Yi Zhang, Kai Treuner, Peter C Lucas, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Dennis C Sgroi, Catherine A Schnabel, Norman Wolmark
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Emily B Jackson, Stephen K L Chia
Sequencing of Endocrine and Targeted Therapies in Hormone-Sensitive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Nicholas C Turner, Cynthia Huang-Bartlett, Kevin Kalinsky, Massimo Cristofanilli, Giampaolo Bianchini, Stephen K L Chia, Hiroji Iwata, Wolfgang Janni, Cynthia X Ma, Erica L Mayer, Jang-Yeon Park, Steven Fox, Xiaochun Liu, Sasha McClain, Francois-Clement Bidard
Design of SERENA-6, a phase III switching trial of camizestrant in ESR1 -mutant breast cancer during first-line treatment. Future oncology (London, England) (2023)
Stephen K L Chia, Phillipe L Bedard, John Hilton, Eitan Amir, Karen Gelmon, Rachel Goodwin, Diego Villa, Michael Cabanero, Dongsheng Tu, Ming Tsao, Lesley Seymour
A Phase Ib Trial of Durvalumab in Combination with Trastuzumab in HER2-Positive Metastatic Breast Cancer (CCTG IND.229). The oncologist 24 (11) (2019)
Stephen K L Chia, Miguel Martin, Frankie A Holmes, Bent Ejlertsen, Suzette Delaloge, Beverly Moy, Hiroji Iwata, Gunter von Minckwitz, Janine Mansi, Carlos H Barrios, Michael Gnant, Zorica Tomašević, Neelima Denduluri, Robert Šeparović, Sung-Bae Kim, Erik Hugger Jakobsen, Vernon Harvey, Nicholas Robert, John Smith, Graydon Harker, Bo Zhang, Lisa D Eli, Yining Ye, Alshad S Lalani, Marc Buyse, Arlene Chan
PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial. Breast cancer research : BCR 21 (1) (2019)